Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 176 clinical trials
Fat Reduction in the Flanks Area vs. Control

Prospective, blinded, one arm, baseline-controlled clinical study for the evaluation the performance of the UltraShape treatment for non-invasive fat reduction by compare control and treated flanks. Study subjects will undergo UltraShape treatments on one randomized flank using the U-Sculpt/VDF Transducer. The second flank will not be treated (control). Both flanks …

Maryland Laser, Skin, & Vein Institute, LLC
 (7.3 away) Contact site
  • 08 Nov, 2020
  • +2 other locations
CRT ShuntCheck "Fit & Function" Study

An exploratory "Fit & Function" study of Continuous Real Time (CRT) ShuntCheck, a non-invasive method for monitoring changes in cerebrospinal fluid (CSF) shunt flow in hydrocephalus patients. The device will be tested on 10 pediatric patients (at Johns Hopkins Hospital) and 10 adult patients (at LifeBridge Health) and results will …

LifeBridge Health, Sinai Hospital of Baltimore (Testing Adult Patients 35 years+)
 (7.7 away) Contact site
  • 07 Nov, 2020
  • 1 location
Treatment of Carpal Tunnel Syndrome With Dynamic Splinting

The Purpose of this study is to examine the effect of using the Carpal Tunnel Dynasplint® System on patients diagnosed with CTS in a randomized, controlled, cross-over study.

nerve conduction
nerve conduction study
  • 07 Nov, 2020
  • 1 location
An Evaluation of Non-invasive ICP Monitoring in Patients Undergoing Invasive ICP Monitoring Via an External Ventricular Drainage (EVD) Device

Invasive intracranial pressure (ICP) monitoring is highly effective, but involves risks. HS-1000 measures ICP non-invasively by assessing the acoustic properties of the patient's head. HS-1000 device, a proprietary new non-invasive ICP monitor, is expected to safely and accurately monitor ICP with minimal discomfort to patients, and provide information about normal …

Sinai Hospital
 (7.7 away) Contact site
  • 07 Nov, 2020
  • +6 other locations
Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate

There is a need for more treatment options for patients with recurrent squamous cell cancer of the head and neck (SCCHN). These tumors usually have a variety of genetic defects that include disruption of the p53 pathway, a pathway that would ordinarily work to prevent the development of tumors. In …

squamous cell carcinoma of head and neck
head and neck cancer
Cancer Center of GBMC
 (9.3 away) Contact site
  • 07 Nov, 2020
  • +4 other locations
RCVS: The Rational Approach to Diagnosis and Treatment

This is a randomized clinical trial of short-acting nimodipine versus twice daily extended release verapamil to treat patients presenting with Reversible Cerebral Vasoconstriction Syndrome (RCVS).

Johns Hopkins Bayview Medical Center
 (9.3 away) Contact site
  • 08 Nov, 2020
  • 1 location
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy

This study compares a colonoscopy preparation composed of magnesium citrate capsules to a preparation of polyethylene glycol solution. The hypothesis is that the magnesium citrate capsules work as well and are better liked by patients due to the lack of taste.

Woodholme Gastroenterology
 (4.3 away) Contact site
  • 07 May, 2020
  • +1 other locations
19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction

Six female patients (>18 years of age, pre-menopausal) who have had loco-regional (lumpectomy and radiation) therapy for breast carcinoma and have been at least one-year disease free will undergo liposuction, the autologous SVF cell fraction will be isolated and labeled with CS-1000 in the operating room without entering cell culture, …

breast reconstruction
breast carcinoma
 (6.5 away) Contact site
  • 20 Jan, 2020
  • 1 location
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

Woodholme Gastroenterology Associates PA
 (4.3 away) Contact site
  • 28 Nov, 2020
  • +866 other locations
A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

This is a Phase III, randomized, double-blind, placebo-controlled, multi-center international study assessing the activity of durvalumab and chemotherapy administered prior to surgery compared with placebo and chemotherapy administered prior to surgery in terms of major pathological response.

Research Site
 (9.3 away) Contact site
  • 26 Nov, 2020
  • +269 other locations